TCG Crossover Management, LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$1.3T
Holdings
33
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (33 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY, INC. | 3,570,206 | $156.7B | 12.39% | |
| 2 | DYNDYNE THERAPEUTICS, INC | 2,650,150 | $75.2B | 5.95% | |
| 3 | CATBUSDASTRIA THERAPEUTICS, INC. | 5,278,928 | $74.3B | 5.87% | |
| 4 | SLNSILENCE THERAPEUTICS PLC | 3,295,350 | $71.2B | 5.63% | |
| 5 | GPCRSTRUCTURE THERAPEUTICS INC | 1,598,421 | $68.5B | 5.42% | |
| 6 | AVTEAEROVATE THERAPEUTICS INC | 2,201,274 | $65.1B | 5.15% | |
| 7 | INBXUSDINHIBRX,INC | 1,750,387 | $61.2B | 4.84% | |
| 8 | KROSKEROS THERAPEUTICS, INC. | 879,344 | $58.2B | 4.60% | |
| 9 | GONGERON CORP | 17,391,639 | $57.4B | 4.54% | |
| 10 | YB4PSAVARA INC. | 10,000,000 | $49.8B | 3.94% | |
| 11 | OCULOCULAR THERAPEUTIX, INC. | 5,319,148 | $48.4B | 3.83% | |
| 12 | COGTCOGENT BIOSCIENCES INC | 6,214,375 | $41.8B | 3.30% | |
| 13 | EWTXEDGEWISE THERAPEUTICS, INC. | 2,272,728 | $41.5B | 3.28% | |
| 14 | MLYSMINERALYS THERAPEUTICS, INC. | 3,185,185 | $41.1B | 3.25% | |
| 15 | MDGLMADRIGAL PHARMACEUTICALS INC | 149,283 | $39.9B | 3.15% | |
| 16 | TRMLTOURMALINE BIO INC | 1,477,593 | $33.8B | 2.68% | |
| 17 | TYRATYRA BIOSCIENCES INC | 1,989,103 | $32.6B | 2.58% | |
| 18 | CMPSCOMPASS PATHWAYS PLC | 3,858,000 | $32.1B | 2.54% | |
| 19 | KURAKURA ONCOLOGY INC | 1,423,642 | $30.4B | 2.40% | |
| 20 | TARSTARSUS PHARMACEUTICALS, INC. | 793,829 | $28.9B | 2.28% | |
| 21 | ADVMCHFADVERUM BIOTECHNOLOGIES, INC. | 2,008,340 | $28.4B | 2.25% | |
| 22 | —SOLENO THERAPEUTIVS, INC. | 550,000 | $23.5B | 1.86% | |
| 23 | CNTACENTESSA PHARMACEUTICALS PLC | 2,040,816 | $23.1B | 1.82% | |
| 24 | ABVXAbivax SA | 1,100,000 | $15.7B | 1.24% | |
| 25 | VTGNUSDVISTAGEN THERAPEUTICS INC | 2,676,580 | $14.1B | 1.12% | |
| 26 | KALVKALVISTA PHARMACEUTICALS, INC | 1,163,356 | $13.8B | 1.09% | |
| 27 | CCCCC4 THERAPEUTICS, INC. | 1,276,574 | $10.4B | 0.82% | |
| 28 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $8.3B | 0.66% | |
| 29 | ANTXAN2 Therapeutics, Inc. | 1,555,118 | $5.1B | 0.40% | |
| 30 | KODKODIAK SCIENCES INC | 899,999 | $4.7B | 0.37% | |
| 31 | VTYXVENTYX BIOSCIENCES, INC | 815,724 | $4.5B | 0.35% | |
| 32 | NKTREURNEKTAR THERAPEUTICS | 4,000,000 | $3.7B | 0.30% | |
| 33 | CABACABALETTA BIO, INC | 86,795 | $1.5B | 0.12% |